Timing Matters in Prediabetes Remission, with Arvid Sandforth, MD
Sandforth discussed his research that found that early prediabetes remission conferred greater protective effects against T2D than later remission.
Related Articles
Adults with Severe Alopecia Improve Anxiety, Depression with Deuruxolitinib Use
These pooled THRIVE-AA1 and THRIVE-AA2 study data highlight improvements in mental health among patients with alopecia given deuruxolitinib.
Clinical Pearls on Managing Allergic Contact Dermatitis, with April Martinez-Dulay, MSN, APRN, FNP-C
During this DERM 2025 interview segment, Martinez-Dulay touches on highlights from her sessions in which she explores allergic contact dermatitis.
Highlighting Recent Topical Options for Psoriasis, with Linda Stein Gold, MD
In a new interview at the DERM2025 Conference, Stein Gold highlighted several topical options for patients with psoriasis outside of topical steroids.
Study Identifies Triggers Beyond GI Infections for Pediatric p-DGBI
A new study highlights stress, concussion, and other early-life factors as key contributors to pediatric pain-predominant DGBIs.
Walking 7000 Steps Per Day Reduces Risk of Chronic Diseases, Cognitive Decline
Findings suggest 7000 steps per day is associated with a reduced risk of health outcomes including mortality, cardiovascular disease, and type 2 diabetes.
Strategies for Differentiating Hair Loss Disorders from Alopecia Areata
This session was titled ‘The Hidden Undercurrent: When Hair Loss Isn’t Alopecia Areata’ and was presented at the DERM 2025 conference by April Armstrong, MD,…
Pharmacist Education Eases Allergic Rhinitis Symptoms but Can’t Replace Care
A randomized trial found pharmacist-led counseling improved allergic rhinitis symptom control but did not enhance adherence, knowledge, or quality of life.
HCPLive – Clinical news for connected physicians
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Patient-Reported Hair Satisfaction with Deuruxolitinib for Severe Alopecia Areata
This summary highlights changes in severe alopecia areata following deuruxolitinib therapy during THRIVE-AA1 and THRIVE-AA2.
Managing Atopic Dermatitis and Prurigo Nodularis, with April Martinez-Dulay, MSN, APRN, FNP-C
In her DERM 2025 conference interview, Martinez-Dulay highlights takeaways from her sessions on atopic dermatitis, prurigo nodularis, and lymphoma.